title: [Syndrome of inappropriate antidiuretic hormone secretion in the course of treatment with venlafaxine--case report].
abstract: Treatment with some drugs may induce hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This is a report of a 52-year-old man who developed hyponatraemia after starting venlafaxine administration. Serum sodium level returned to the normal range following discontinuation of venlafaxine and application of SIADH--treatment within a few days. The study shows that routine assessment of blood electrolytes is needed in patients treated with drugs affecting vasopresin secretion.
authors.affiliation: II Klinika Psychiatrii IPiN w Warszawie.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Chojnacka
authors.forename: Łukasz
authors.initials: Ł
authors.lastname: Swiecicki
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects*; D003863:Depression / Q000188:drug therapy*; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced* / Q000517:prevention & control; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride